![](https://i0.wp.com/www.cleangrowthfund.com/wp-content/uploads/2023/04/CAM12630.jpg?resize=640%2C427&ssl=1)
![](https://i0.wp.com/www.cleangrowthfund.com/wp-content/uploads/2024/03/hydregen-1.png?resize=300%2C100&ssl=1)
Head Office Oxford
CEO Dr Holly Reeve
CSO Dr Sarah Cleary
CGF Board Rep Susannah McClintock
HydRegen is pioneering the production of bio-based catalysts that enable cleaner, safer and more energy-efficient manufacturing processes for the global pharmaceutical and chemicals industries. Their innovative biotechnology aims to deliver huge CO₂ savings and operating costs by replacing toxic metal catalysts with environmentally and economically friendly bio-based alternatives.
Picture credits: www.charlieflounders.com